R-CHOP regimen can significantly decrease the risk of disease relapse and progression in patients with non-germinal center B-cell subtype diffuse large B-cell lymphoma.
He XH, Li B, Yang S, Lu N, Zhang X, Zou SM, Li YX, Song YW, Zheng S, Dong M, Zhou SY, Yang JL, Liu P, Zhang CG, Qin Y, Feng FY, Shi YK.
He XH, et al. Among authors: zhang cg, zhang x.
Chin J Cancer. 2012 Jun;31(6):306-14. doi: 10.5732/cjc.011.10420. Epub 2012 May 23.
Chin J Cancer. 2012.
PMID: 22640627
Free PMC article.